Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pidnarulex by Senhwa Biosciences for Prostate Cancer: Likelihood of Approval
Pidnarulex is under clinical development by Senhwa Biosciences and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...